PTEN and neoplasm: Through inhibition of the phosphoinositide 3-kinase (PI3K)/Akt pathway, PTEN can suppress multiple downstream pathways required for tumor growth by preventing activation of the mechanistic target of Rapamycin complex 1 (mTORC1) [3].